# S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

> **NCT00062439** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 46 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** etoposide
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00062439
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2013-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062439, "S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00062439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*